Neostatin-7 regulates bFGF-induced corneal lymphangiogenesis

FEBS Letters

Volumn 582, Issue 17, 2008, Pages 2515-2520

  Kojima, Takashi ^a   Azar, Dimitri T ^a   Chang, Jin Hong ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

bFGF; Collagen XVIII; Endostatin; Lymphangiogenesis; Neostatin 7

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; PROTEIN NEOSTATIN 7; RECOMBINANT PROTEIN; VASCULOTROPIN; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 3;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; ENZYME BINDING; KERATECTOMY; LYMPHANGIOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANGIOGENESIS INHIBITORS; ANIMALS; COLLAGEN TYPE XVIII; CORNEA; CORNEAL NEOVASCULARIZATION; CORNEAL SURGERY, LASER; FIBROBLAST GROWTH FACTORS; LYMPHANGIOGENESIS; MICE; MICE, KNOCKOUT; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3; WOUNDS AND INJURIES;

MUS;

EID: 46749140198     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2008.06.014     Document Type: Article

References (33)

1. Ji R.C. Lymphatic endothelial cells, lymphangiogenesis, and extracellular matrix. Lymphat. Res. Biol. 4 (2006) 83-100
2. Hirakawa S., and Detmar M. New insights into the biology and pathology of the cutaneous lymphatic system. J. Dermatol. Sci. 35 (2004) 1-8
3. He Y., et al. Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res. 65 (2005) 4739-4746
4. Ambati B.K., et al. Corneal avascularity is due to soluble VEGF receptor-1. Nature 443 (2006) 993-997
5. Cursiefen C., et al. Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision. Proc. Natl. Acad. Sci. USA 103 (2006) 11405-11410
6. Karkkainen M.J., Ferrell R.E., Lawrence E.C., Kimak M.A., Levinson K.L., McTigue M.A., Alitalo K., and Finegold D.N. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat. Genet. 25 (2000) 153-159
7. Hamada K., Oike Y., Takakura N., Ito Y., Jussila L., Dumont D.J., Alitalo K., and Suda T. VEGF-C signaling pathways through VEGFR-2 and VEGFR-3 in vasculoangiogenesis and hematopoiesis. Blood 96 (2000) 3793-3800
8. Lin J., et al. Inhibition of lymphogenous metastasis using adeno-associated virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor. Cancer Res. 65 (2005) 6901-6909
9. Laakkonen P., et al. Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growth. Cancer Res. 67 (2007) 593-599
10. Karkkainen M.J., et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat. Immunol. 5 (2004) 74-80
11. Karkkainen M.J., and Petrova T.V. Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis. Oncogene 19 (2000) 5598-5605
12. Sasaki T., Fukai N., Mann K., Gohring W., Olsen B.R., and Timpl R. Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin. EMBO J. 17 (1998) 4249-4256
13. Ferreras M., Felbor U., Lenhard T., Olsen B.R., and Delaisse J. Generation and degradation of human endostatin proteins by various proteinases. FEBS Lett. 486 (2000) 247-251
14. Ma D.H., et al. Generation of endostatin by matrix metalloproteinase and cathepsin from human limbocorneal epithelial cells cultivated on amniotic membrane. Invest. Ophthalmol. Vis. Sci. 48 (2007) 644-651
15. O'Reilly M.S., et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88 (1997) 277-285
16. Chang J.H., Javier J.A., Chang G.Y., Oliveira H.B., and Azar D.T. Functional characterization of neostatins, the MMP-derived, enzymatic cleavage products of type XVIII collagen. FEBS Lett. 579 (2005) 3601-3606
17. Folkman J. Antiangiogenesis in cancer therapy - endostatin and its mechanisms of action. Exp. Cell Res. 312 (2006) 594-607
18. Kim Y.M., Hwang S., Kim Y.M., Pyun B.J., Kim T.Y., Lee S.T., Gho Y.S., and Kwon Y.G. Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1. J. Biol. Chem. 277 (2002) 27872-27879
19. Teodoro J.G., Parker A.E., Zhu X., and Green M.R. p53-mediated inhibition of angiogenesis through up-regulation of a collagen prolyl hydroxylase. Science 313 (2006) 968-971
20. Chen L., Hamrah P., Cursiefen C., Zhang Q., Pytowski B., Streilein J.W., and Dana M.R. Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity. Nat. Med. 10 (2004) 813-815
21. Brideau G., Makinen M.J., Elamaa H., Tu H., Nilsson G., Alitalo K., Pihlajaniemi T., and Heljasvaara R. Endostatin overexpression inhibits lymphangiogenesis and lymph node metastasis in mice. Cancer Res. 67 (2007) 11528-11535
22. Kato T., Kure T., Chang J.H., Gabison E.E., Itoh T., Itohara S., and Azar D.T. Diminished corneal angiogenesis in gelatinase A-deficient mice. FEBS Lett. 508 (2001) 187-190
23. Kenyon B.M., Voest E.E., Chen C.C., Flynn E., Folkman J., and D'Amato R.J. A model of angiogenesis in the mouse cornea. Invest. Ophthalmol. Vis. Sci. 37 (1996) 1625-1632
24. Kubo H., Cao R., Brakenhielm E., Makinen T., Cao Y., and Alitalo K. Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea. Proc. Natl. Acad. Sci. USA 99 (2002) 8868-8873
25. Lin H.C., Chang J.H., Jain S., Gabison E.E., Kure T., Kato T., Fukai N., and Azar D.T. Matrilysin cleavage of corneal collagen type XVIII NC1 domain and generation of a 28-kDa fragment. Invest. Ophthalmol. Vis. Sci. 42 (2001) 2517-2524
26. Bhutto I.A., Kim S.Y., McLeod D.S., Merges C., Fukai N., Olsen B.R., and Lutty G.A. Localization of collagen XVIII and the endostatin portion of collagen XVIII in aged human control eyes and eyes with age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 45 (2004) 1544-1552
27. Halfter W., Dong S., Schurer B., and Cole G.J. Collagen XVIII is a basement membrane heparan sulfate proteoglycan. J. Biol. Chem. 273 (1998) 25404-25412
28. Reis R.C., Schuppan D., Barreto A.C., Bauer M., Bork J.P., Hassler G., and Coelho-Sampaio T. Endostatin competes with bFGF for binding to heparin-like glycosaminoglycans. Biochem. Biophys. Res. Commun. 333 (2005) 976-983
29. Vazquez F., Hastings G., Ortega M.A., Lane T.F., Oikemus S., Lombardo M., and Iruela-Arispe M.L. METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity. J. Biol. Chem. 274 (1999) 23349-23357
30. Fukai N., et al. Lack of collagen XVIII/endostatin results in eye abnormalities. EMBO J. 21 (2002) 1535-1544
31. Li Q., and Olsen B.R. Increased angiogenic response in aortic explants of collagen XVIII/endostatin-null mice. Am. J. Pathol. 165 (2004) 415-424
32. Moulton K.S., Olsen B.R., Sonn S., Fukai N., Zurakowski D., and Zeng X. Loss of collagen XVIII enhances neovascularization and vascular permeability in atherosclerosis. Circulation 110 (2004) 1330-1336
33. Kure T., et al. Corneal neovascularization after excimer keratectomy wounds in matrilysin-deficient mice. Invest. Ophthalmol. Vis. Sci. 44 (2003) 137-144